Rates of Peripheral Arterial Occlusive Disease in Patients With Chronic Myeloid Leukemia in the Chronic Phase Treated With Imatinib, Nilotinib, or Non-Tyrosine Kinase Therapy: A Retrospective Cohort Analysis
Leukemia - United Kingdom
doi 10.1038/leu.2013.69
Full Text
Open PDFAbstract
Available in full text
Date
March 5, 2013
Authors
Publisher
Springer Science and Business Media LLC